A case of confusion and bilateral temporal lesions in a young woman
Citation Manager Formats
Make Comment
See Comments

A 43-year-old right-handed woman with a medical history significant for methamphetamine abuse was admitted after presenting with a rapidly worsening confusion. The patient's family described 3 weeks of progressive disorientation, memory problems, anorexia with weight loss, and bilateral lower extremity neuropathic pain. Her only other pertinent medical history included a 10-pack-year history of tobacco use.
On examination, her vital signs were normal except for a sinus tachycardia. She scored 15/30 on the Mini-Mental State Examination with loss of points primarily on orientation, recall, and attention. There were no abnormalities of her cranial nerves, motor examination, coordination, or gait. Sensory examination demonstrated mild hypoesthesia over her feet, otherwise normal.
Initial laboratory values included a normal complete blood count, complete metabolic panel, and negative rapid plasmin reagin, HIV, and antinuclear antibodies. She had a positive toxicology screen for methamphetamine and a low-normal vitamin B12 level of 282. Her CSF analysis had 4 mononuclear white blood cells, an elevated protein of 142, normal glucose, and 14 oligoclonal bands present. CSF culture was negative and herpes simplex virus 1/2 and human herpesvirus–6 PCR were negative as well.
Her brain MRI showed abnormal signal bilaterally in the temporal lobes extending into the left insular cortex on fluid-attenuated inversion recovery sequence (figure 1) without contrast enhancement. An EEG was performed and showed nonspecific diffuse theta slowing with no epileptiform discharges or seizures.
Brain MRI: Diffuse, confluent T2 hyperintensities along bilateral mesial temporal lobes (A); extending into the left insular cortex (B).
Based on the presentation, MRI, and lumbar puncture, the differential included infectious encephalitis (i.e., herpes simplex virus–1), bilateral infarction, or toxic effect, from methamphetamine use, Hashimoto encephalopathy, or paraneoplastic/autoimmune limbic encephalitis. She was started on IV acyclovir, but her clinical course continued to decline with development of paranoid delusions by hospital day 5.
A subsequent CT of chest, abdomen, and pelvis was normal except for subcarinal and right hilar lymphadenopathy. The patient then underwent a biopsy of a subcarinal lymph node with the final pathology consistent with a large-cell neuroendocrine carcinoma consistent with lung primary (figure 2).
Hematoxylin-eosin stain lymph node biopsy (60×): Large tumor cells (20–50 μm) with both salt-and-pepper and vesicular chromatin with robust mitotic activity. Immunohistochemical stains showed diffuse CD-56 and chromogranin positivity with positive TTF-1 staining consistent with lung primary.
The CSF paraneoplastic panel eventually returned with a positive anti-Hu antibody. Based on pathology, MRI brain, and CSF anti-Hu antibody, she was diagnosed with an anti-Hu–associated paraneoplastic limbic encephalitis with primary large-cell neuroendocrine carcinoma of the lung. She was treated with 5 days of plasma exchange with IV methylprednisolone without improvement in her mental status and then received 1 cycle of carboplatin and etoposide for her carcinoma. She showed no improvement over the following months and was eventually transferred to hospice care.
Large-cell neuroendocrine carcinoma of the lung (LCNEC) is histochemically similar to neuroendocrine tumors and morphologically similar to large-cell carcinomas.1 They represent approximately 2%–3% of malignant pulmonary neoplasms and generally have a poorer stage-for-stage survival with treatment than other non-small-cell lung cancers. The mean age of patients with LCNEC ranges from 62 to 68 years and smoking appears to be a significant risk for development of LCNEC.1
Large-cell neuroendocrine carcinoma of the lung has been associated with several paraneoplastic syndromes. These include a paraneoplastic retinopathy,2 voltage-gated calcium channel antibody-mediated Lambert-Eaton syndrome,3 and an anti-Hu–positive syndrome with painful sensory neuropathy, autonomic dysfunction, and tonic pupils.4 LCNEC is rarely associated with anti-Hu–associated limb encephalitis. In one series of 167 patients with anti-Hu–associated encephalomyelitis, only 4 (2.4%) had primary neuroendocrine carcinoma of the lung.5 The most common cause in the same study was small-cell lung cancer with 111 (66%) cases.
The typical evaluation for a suspected paraneoplastic limbic encephalitis includes serum and CSF paraneoplastic antibodies; MRI of the brain; CT scan of the chest, abdomen, and pelvis; and testicular ultrasound in men. CT scans alone, however, can miss small neoplasms. Recent evidence has shown that PET-CT may improve the detection rate of cancer in patients with a paraneoplastic disorder when more standard evaluations are negative.6
This case illustrates a common clinical presentation and MRI brain of a paraneoplastic limbic encephalitis. What is uncommon is the underlying primary malignancy and demonstrates that large-cell neuroendocrine tumors should be considered in the differential of anti-Hu–associated limbic encephalitis.
Footnotes
Disclosure: Dr. West receives a Neuroimmunology Fellowship currently sponsored by Biogen Idec. Dr. Young Barbee is an employee of Kaiser Permanente.
- Received August 5, 2010.
- Accepted September 2, 2010.
- Copyright © 2010 by AAN Enterprises, Inc.
References
- 1.↵
- 2.↵
- Stanford MR,
- Edelsten CE,
- Hughes JD,
- et al
- 3.↵
- 4.↵
- Gordon WC,
- Leach M
- 5.↵
- Graus F,
- Keime-Guibert F,
- Rene R,
- et al
- 6.↵
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disordersA. Boronat, L. Sabater, A. Saiz et al.Neurology, February 28, 2011 -
Brief Communications
Paraneoplastic encephalomyelitis and seminomaImportance of testicular ultrasonographyDean M. Wingerchuk, John H. Noseworthy, David W. Kimmel et al.Neurology, November 01, 1998 -
Article
Neurologic autoimmunity and immune checkpoint inhibitorsAutoantibody profiles and outcomesElia Sechi, Svetomir N. Markovic, Andrew McKeon et al.Neurology, August 13, 2020 -
Articles
Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodiesClaudia F. Lucchinetti, David W. Kimmel, Vanda A. Lennon et al.Neurology, March 01, 1998